A review of guidelines for antibacterial use in acute exacerbations of chronic bronchitis

Pulmonary Pharmacology and Therapeutics

Volumn 19, Issue 5, 2006, Pages 361-369

  Blasi, Francesco ^a   Ewig, Santiago ^b   Torres, Antoni ^c   Huchon, Gerard ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b ST JOSEF HOSPITAL   (Germany)

^c HOSPITAL CLÍNIC   (Spain)

^d HÔTEL DIEU   (France)

Author keywords

Acute exacerbations of chronic bronchitis; Antibacterials; Ketolides; Telithromycin; Treatment guidelines

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFETAMET PIVOXIL; CEFIXIME; CEFOTIAM HEXETIL; CEFPODOXIME PROXETIL; CEFPROZIL; CEFTIBUTEN; CEFUROXIME AXETIL; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DIRITHROMYCIN; DOXYCYCLINE; GATIFLOXACIN; KETOLIDE; LEVOFLOXACIN; LORACARBEF; MACROLIDE; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TELITHROMYCIN; UNINDEXED DRUG;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; CHRONIC BRONCHITIS; COMORBIDITY; DISEASE EXACERBATION; DRUG USE; HAEMOPHILUS INFLUENZAE; HEALTH CARE UTILIZATION; HUMAN; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BRONCHITIS, CHRONIC; FLUOROQUINOLONES; HUMANS; KETOLIDES; PRACTICE GUIDELINES; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 33746079304     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2005.09.004     Document Type: Article

References (50)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152 (1995) S77-S121
2. Sethi S., Evans N., Grant B.J., and Murphy T.F. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 347 (2002) 465-471
3. Ball P., and Make B. Acute exacerbations of chronic bronchitis: an international comparison. Chest 113 Suppl 3 (1998) 199S-204S
4. McGuire A., Irwin D.E., Fenn P., et al. The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales. Value Health 4 (2001) 370-375
5. Anthonisen N.R., Manfreda J., Warren C.P., Hershfields E.S., Harding G.K., and Nelson N.A. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106 (1987) 196-204
6. Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest 117 5 Suppl 2 (2000) 380S-385S
7. Rosell A., Monso E., Soler N., et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 165 (2005) 891-897
8. Sethi S. Infectious exacerbations of chronic bronchitis: diagnosis and management. J Antimicrob Chemother 43 Suppl A (1999) 97-105
9. Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest 108 Suppl 2 (1995) 43S-52S
10. Rohde G., Wiethege A., Borg I., et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 58 (2003) 37-42
11. Niederman M.S., McCombs J.S., Unger A.N., Kumar A., and Popovian R. Treatment cost of acute exacerbations of chronic bronchitis. Clin Ther 21 (1999) 576-591
12. Miravitlles M., Murio C., Guerrero T., Gisbert R., and on behalf of the DAFNE Study Group. Decisiones Sobre Antibioticoterapia y Farmacoeconomia en la EPOC. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 121 (2002) 1449-1455
13. Saint S., Bent S., Vittinghoff E., and Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. JAMA 273 (1995) 957-960
14. Allegra L., Blasi F., de Bernardi B., Consentini R., and Tarsia P. Antibiotic treatment and baseline severity of disease in acute exacerbations of chronic bronchitis: a re-evaluation of previously published data of a placebo-controlled randomized study. Pulm Pharmacol Ther 14 (2001) 149-155
15. Nouira S., Marghli S., Belghith M., Besbes L., Elatrous S., and Abroug F. Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial. Lancet 358 (2001) 2020-2025
16. Niewoehner D.E. The role of systemic corticosteroids in acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Med 1 (2002) 243-248
17. Wilson R., Allegra L., Huchon G., et al. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. Chest 125 (2004) 953-964
18. Fagon J.Y., Chastre J., Trouillet J.L., et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis 142 (1990) 1004-1008
19. Monso E., Ruiz J., Rosell A., et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 152 4 Pt 1 (1995) 1316-1320
20. Pela R., Marchesani F., Agostinelli C., et al. Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation. Monaldi Arch Chest Dis 53 (1998) 262-267
21. Soler N., Torres A., Ewig S., et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 157 (1998) 1498-1505
22. Mogulkoc N., Karakurt S., Isalska B., et al. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am J Respir Crit Care Med 160 (1999) 349-353
23. Eller J., Ede A., Schaberg T., Niederman M.S., Mauch H., and Lode H. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 113 (1998) 1542-1548
24. Miravitlles M., Espinosa C., Fernandez-Laso E., Martos J.A., Maldonado J.A., and Gallego M. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Chest 116 (1999) 40-46
25. Hoban D.J., Doern G.V., Fluit A.C., Roussel-Delvallez M., and Jones R.N. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 32 Suppl 2 (2001) S81-S93
26. Felmingham D. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. J Infect 44 Suppl A (2002) 3-10
27. Hoban D., Waites K., and Felmingham D. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in North America in 1999-2000: findings of the PROTEKT surveillance study. Diagn Microbiol Infect Dis 45 (2003) 251-259
28. Felmingham D., Grüneberg R.N., and and the Alexander Project Group. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 45 (2000) 191-203
29. Jacobs M.R., Felmingham D., Appelbaum P.C., Grüneberg R.N., and and the Alexander Project Group. The Alexander project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 52 (2003) 229-246
30. Gordon K.A., Biedenbach D.J., and Jones R.N. Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 46 (2003) 285-289
31. Hoban D., and Felmingham D. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. J Antimicrob Chemother 50 Suppl S1 (2002) 49-59
32. Felmingham D., Reinert R.R., Hirakata Y., and Rodloff A. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother 50 Suppl S1 (2002) 25-37
33. Rzeszutek M., Wierzbowski A., Hoban D.J., Conly J., Bishai W., and Zhanel G.G. A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae. Int J Antimicrob Agents 24 (2004) 95-104
34. Niederman M.S. Appropriate use of antimicrobial agents: challenges and strategies for improvement. Crit Care Med 31 (2003) 608-616
35. Brown E.M., and Nathwani D. Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. J Antimicrob Chemother 55 (2005) 6-9
36. Ruhe J.J., and Hasbun R. Streptococcus pneumoniae bacteremia: duration of previous antibiotic use and association with penicillin resistance. Clin Infect Dis 36 (2003) 1132-1188
37. Stockley R.A., O'Brien C., Pye A., and Hill S.L. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 117 (2000) 1638-1645
38. Agence Française de Sécurité Sanitaire des Produits de Santé. Mise au point sur l'antibiothérapie par voie générale en pratique courante (2002). http://afssaps.sante.fr/htm/10/filltrpsc/antibio.pdf (accessed March 2004).
39. Société de Pneumologie de Langue Française. Guidelines for the clinical management of COPD. Exacerbations/acute respiratory failure: antibiotherapy. Rev Mal Respir 20 3 Pt 2 (2003) S65-S68 [in French]
40. Alvarez F., Bouza E., Garcia-Rodriguez J.A., et al. Second consensus report on the use of antimicrobial agents in exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol 39 (2003) 274-282 [in Spanish]
41. Vogel F., Scholz H., al-Nawas B., et al. Rational use of oral antibiotics. (Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy). Chemother J 11 (2002) 47-58 [in German]
42. Blasi F., Bulfoni A., Concia E., et al. Riacutizzazioni di bronchite cronica. GIMI 1 Suppl 2 (2002) 24-39
43. Balter M.S., La Forge J., Low D.E., Mandell L., Grossman R.F., and on behalf of the Canadian Thoracic Society and the Canadian Infectious Disease Society. Canadian guidelines for the management of acute exacerbations of chronic bronchitis. Can Respir J 10 Suppl B (2003) 3B-32B
44. American Thoracic Society and European Respiratory Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (2004). http://www.thoracic.org/COPD/ (accessed June 2004).
45. Grupo de trabajo de la Asociacion Latinoamericana del Torax (ALAT). Update to the Latin American Thoracic Association (ALAT) recommendations on infectious exacerbation of chronic obstructive pulmonary disease. Arch Bronconeumol 40 (2004) 315-325
46. Sethi S., Anzueto A., and Farrell D.J. Antibiotic activity of telithromycin and comparators against bacterial pathogens isolated from 3043 patients with acute exacerbation of chronic bronchitis. Ann Clin Microbiol Antimicrob 4 (2005) 5
47. Livermore D.M., James D., Reacher M., et al. Trends in fluoroquinolone (ciprofloxacin) resistance in Enterobacteriaceae from bacteremias, England and Wales, 1990-1999. Emerg Infect Dis 8 (2002) 473-478
48. Chen D.K., McGeer A., de Azavedo J.C., and Lowe D.E. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med 341 (1999) 233-239
49. Goldstein E.J., and Garabedian-Ruffalo S.M. Widespread use of fluoroquinolones versus emerging resistance in pneumococci. Clin Infect Dis 35 (2002) 1505-1511
50. Wilson R., Schentag J.J., Ball P., Mandell L., and on behalf of the 068 Study Group. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes. Clin Ther 24 (2002) 639-652